These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8218104

  • 1. Parental history of early myocardial infarction is associated with decreased levels of lipoparticle AI in adolescents.
    Amouyel P, Isorez D, Bard JM, Goldman M, Lebel P, Zylberberg G, Fruchart JC.
    Arterioscler Thromb; 1993 Nov; 13(11):1640-4. PubMed ID: 8218104
    [Abstract] [Full Text] [Related]

  • 2. Atherogenic lipoprotein profile in families with and without history of early myocardial infarction.
    Dobiásová M, Raslová K, Rauchová H, Vohnout B, Ptácková K, Frohlich J.
    Physiol Res; 2001 Nov; 50(1):1-8. PubMed ID: 11300220
    [Abstract] [Full Text] [Related]

  • 3. Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family study: Associations with metabolic risk profile variables.
    Couillard C, Bergeron J, Després JP, Gagnon J, Rankinen T, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C.
    Metabolism; 2003 Dec; 52(12):1530-6. PubMed ID: 14669150
    [Abstract] [Full Text] [Related]

  • 4. Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
    Peacock RE, Hamsten A, Johansson J, Nilsson-Ehle P, Humphries SE.
    Clin Genet; 1994 Oct; 46(4):273-82. PubMed ID: 7834891
    [Abstract] [Full Text] [Related]

  • 5. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men.
    Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB.
    Circulation; 2005 Nov 29; 112(22):3375-83. PubMed ID: 16316964
    [Abstract] [Full Text] [Related]

  • 6. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, Stornaiuolo V, Trevisan M.
    Nutr Metab Cardiovasc Dis; 2008 Sep 29; 18(7):492-6. PubMed ID: 17962002
    [Abstract] [Full Text] [Related]

  • 7. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L, Raimondo G, Di Benedetto A, Romano G, Porcellini A, Campo S, Corica F, Riccardi G, Squadrito G, Cucinotta D.
    Acta Diabetol; 1995 Dec 29; 32(4):251-6. PubMed ID: 8750764
    [Abstract] [Full Text] [Related]

  • 8. Serum apolipoproteins AI and B and lipoproteins in middle aged men with and without previous myocardial infarction.
    Durrington PN, Hunt L, Ishola M, Kane J, Stephens WP.
    Br Heart J; 1986 Sep 29; 56(3):206-12. PubMed ID: 3092846
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF, Barrett PH, Ji J, Serone AP, Chan DC, Croft KD, Loehrer F, Johnson AG.
    Diabetes; 2003 Mar 29; 52(3):803-11. PubMed ID: 12606523
    [Abstract] [Full Text] [Related]

  • 10. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
    Sacks FM, Alaupovic P, Moye LA, Cole TG, Sussex B, Stampfer MJ, Pfeffer MA, Braunwald E.
    Circulation; 2000 Oct 17; 102(16):1886-92. PubMed ID: 11034934
    [Abstract] [Full Text] [Related]

  • 11. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.
    Parish S, Peto R, Palmer A, Clarke R, Lewington S, Offer A, Whitlock G, Clark S, Youngman L, Sleight P, Collins R, International Studies of Infarct Survival Collaborators.
    Eur Heart J; 2009 Sep 17; 30(17):2137-46. PubMed ID: 19520708
    [Abstract] [Full Text] [Related]

  • 12. Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.
    Buring JE, O'Connor GT, Goldhaber SZ, Rosner B, Herbert PN, Blum CB, Breslow JL, Hennekens CH.
    Circulation; 1992 Jan 17; 85(1):22-9. PubMed ID: 1728453
    [Abstract] [Full Text] [Related]

  • 13. The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study).
    Luc G, Bard JM, Evans A, Arveiler D, Ruidavets JB, Amouyel P, Ducimetiere P.
    Atherosclerosis; 2000 Oct 17; 152(2):399-405. PubMed ID: 10998468
    [Abstract] [Full Text] [Related]

  • 14. [Serum apolipoproteins A-1 and B in young males with a history of myocardial infarction].
    Vetrov AV, Metel'skaia VA, Gerasimova EN, Barats SS, Perova NV.
    Kardiologiia; 1984 Oct 17; 24(10):87-90. PubMed ID: 6441062
    [Abstract] [Full Text] [Related]

  • 15. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ, van Gent CM, Buytenhek R, Buis B.
    J Lab Clin Med; 1987 Jan 17; 109(1):19-26. PubMed ID: 3098880
    [Abstract] [Full Text] [Related]

  • 16. Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII.
    Gottrand F, Beghin L, Duhal N, Lacroix B, Bonte JP, Fruchart JC, Luc G.
    Eur J Clin Invest; 1999 May 17; 29(5):387-94. PubMed ID: 10354195
    [Abstract] [Full Text] [Related]

  • 17. Interstitial fluid apolipoprotein A-II: an association with the occurrence of myocardial infarction.
    Luc G, Majd Z, Poulain P, Elkhalil L, Fruchart JC.
    Atherosclerosis; 1996 Nov 15; 127(1):131-7. PubMed ID: 9006813
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.